Robert Clark
Vermogen: 8 375 $ op 31-05-2026
Vermogen: 8 375 $ op 31-05-2026
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2023 and Novo Nordisk, Inc., as Vice President-US Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Incannex Healthcare Pty Ltd., as Director from 2022 to 2023 and Pfizer Inc., as VP-Worldwide Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-11-2025 | 2.500 ( 0,02% ) | 8 375 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Bestuurslid | 01-11-2023 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Algemeen Adviseur | 01-01-2012 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01-01-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Incannex Healthcare, Inc.
Incannex Healthcare, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cannabinoid and psychedelic compound medicines | Health Technology |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau